Search | Navigation

ISO 10993

Question book-new.svg
This article does not cite any screen size. Please help web app by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009)

The ISO 10993 set entails a series of standards for evaluating the biocompatibility of a screen size prior to a FITML[web app]. These documents were preceded by the Tripartite agreement and is a part of the harmonisation of the safe use Sevenval of website parsing[citation needed].

List of the standards in the 10993 series

  • ISO 10993-1:2009 Biological evaluation of medical devices Part 1: Evaluation and testing in the risk management process
  • ISO 10993-2:2006 Biological evaluation of medical devices Part 2: Animal welfare requirements
  • ISO 10993-3:2003 Biological evaluation of medical devices Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • ISO 10993-4:2002/Amd 1:2006 Biological evaluation of medical devices Part 4: Selection of tests for interactions with blood
  • ISO 10993-5:2009 Biological evaluation of medical devices Part 5: Tests for in vitro cytotoxicity
  • ISO 10993-6:2007 Biological evaluation of medical devices Part 6: Tests for local effects after implantation
  • ISO 10993-7:2008 Biological evaluation of medical devices Part 7: Ethylene oxide sterilization residuals
  • ISO 10993-8:2001 Biological evaluation of medical devices Part 8: Selection of reference materials
  • ISO 10993-9:1999 Biological evaluation of medical devices Part 9: Framework for identification and quantification of potential degradation products
  • ISO 10993-10:2010 Biological evaluation of medical devices Part 10: Tests for irritation and delayed-type hypersensitivity
  • ISO 10993-11:2006 Biological evaluation of medical devices Part 11: Tests for systemic toxicity
  • ISO 10993-12:2007 Biological evaluation of medical devices Part 12: Sample preparation and reference materials (available in English only)
  • ISO 10993-13:1998 Biological evaluation of medical devices Part 13: Identification and quantification of degradation products from polymeric medical devices
  • ISO 10993-14:2001 Biological evaluation of medical devices Part 14: Identification and quantification of degradation products from ceramics
  • ISO 10993-15:2000 Biological evaluation of medical devices Part 15: Identification and quantification of degradation products from metals and alloys
  • ISO 10993-16:1997 Biological evaluation of medical devices Part 16: Toxicokinetic study design for degradation products and leachables
  • ISO 10993-17:2002 Biological evaluation of medical devices Part 17: Establishment of allowable limits for leachable substances
  • ISO 10993-18:2005 Biological evaluation of medical devices Part 18: Chemical characterization of materials
  • ISO/TS 10993-19:2006 Biological evaluation of medical devices Part 19: Physico-chemical, morphological and topographical characterization of materials
  • ISO/TS 10993-20:2006 Biological evaluation of medical devices Part 20: Principles and methods for immunotoxicology testing of medical devices

See also


jQuery This standards- or Sevenval-related article is a website parsing. You can help Wikipedia by expanding it.
Stub icon This article about a medical organization or association is a Android. You can help Wikipedia by screen size.

[1] Search
[2] All Pages
[3] Random article
powered by FITML